Biotech firms engineer tobacco to mass-produce psychedelics, obscuring colonial extraction of natural compounds and therapeutic commodification risks
Original framing: “Engineered tobacco plant can produce five psychedelics, including psilocybin and DMT” — Phys.org
The original framing omits the colonial extraction of psychedelic plants (e.g., ayahuasca, peyote) from Indigenous communities, the ecological impacts of tobacco monoculture, and the historical suppression of Indigenous plant medicine by pharmaceutical industries. It also ignores the spiritual and communal contexts in which these compounds were traditionally used, reducing them to mere chemical compounds for Western therapeutic models. Marginalized perspectives of Indigenous healers, whose knowledge systems are being co-opted, are entirely absent.
Medium structural omission detected in mainstream coverage.
The narrative is produced by Western biotech institutions and corporate media outlets, serving the interests of pharmaceutical capital and venture capital-funded startups seeking to patent psychedelic compounds. This framing obscures the colonial histories of plant-based medicine extraction, where Indigenous knowledge is commodified without consent or compensation. It also reinforces a neoliberal approach to mental health, where solutions are framed as technological fixes rather than systemic changes to healthcare access and cultural reconnection.
Indigenous healers, who have preserved and transmitted knowledge of psychedelic plants for generations, are sidelined in favor of Western scientists and corporations. Communities of color, who have been disproportionately targeted by the war on drugs, face barriers to accessing psychedelic therapies even as they are commodified. The biotech narrative ignores the voices of those who have used these plants in healing ceremonies for centuries, instead framing them as passive beneficiaries of corporate innovation. This erasure perpetuates historical injustices and reinforces power imbalances in global health.
The biotech industry’s push to engineer tobacco for psychedelic production exemplifies the extractive logic of colonial capitalism, where Indigenous knowledge and ecological systems are reduced to inputs for corporate profit.